Ipogras Chile

Laboratorio Chile is the leading pharmaceutical company in Chile, specializing in the development, manufacturing, and commercialization of a broad portfolio of generic and branded generic medicines. As a key subsidiary of Teva Pharmaceutical Industries, the company provides affordable healthcare solutions across numerous therapeutic areas, including metabolic health, cardiovascular disease, and central nervous system disorders. One of its most prominent brands is Ipogras (orlistat), a widely recognized treatment for obesity and weight management in the Chilean market. The company operates extensive manufacturing and distribution facilities in Santiago, serving both the public and private healthcare sectors and maintaining a dominant market share in the region.